We’re pleased to announce that our team at JensonR+ have released our first Investigational Medicinal Products (IMP) batch. Our quality team have made the final sign-off marking the culmination of the quality process through which a batch of IMP has been shown to conform to all aspects of Good Manufacturing Practice (GMP).
Are you ready for the post-Brexit model? Time is running out to get things in order. We have created a timeline to help identify where your pressure points may lie.
Pharmaceutical companies and in particular small to medium sized ones, are in a perpetual battle to increase efficiency and reduce costs while staying GMP compliant. The always moving landscape of regulatory compliance puts significant demands on the sometimes-limited resources available to these companies. This can result in the prioritisation of activities of seemingly more importance which will inevitably, despite best efforts, lead to the neglect of others.
